Comparative study between fibro-test and egy-score as non-invasive markers for assessment of hepatic fibrosis in chronic hepatitis c

ABSTRACT

Backgound Liver fibrosis [LF] occurs in response to almost all causes of chronic liver injury. Assessing LF is important for both predicting disease progression and monitoring efficacy of therapeutic measures. Most noninvasive tests of liver fibrosis were developed with the aim of discriminating between ginsignificanth, [F0-F1] by METAVIR and clinically gsignificanth fibrosis [. F2] by METAVIR or for identifying or excluding established cirrhosis in patients with well compensated chronic liver disease. Both these aims are clinically the most relevant